Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Mucosal immune response in biology, disease prevention and treatment
X Zhou, Y Wu, Z Zhu, C Lu, C Zhang, L Zeng… - … and Targeted Therapy, 2025 - nature.com
The mucosal immune system, as the most extensive peripheral immune network, serves as
the frontline defense against a myriad of microbial and dietary antigens. It is crucial in …
the frontline defense against a myriad of microbial and dietary antigens. It is crucial in …
A multivalent and thermostable nanobody neutralizing SARS-CoV-2 omicron (B. 1.1. 529)
Y Lu, Q Li, H Fan, C Liao, J Zhang, H Hu… - International Journal …, 2023 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variants have risen to dominance, which contains far more mutations in the spike protein in …
variants have risen to dominance, which contains far more mutations in the spike protein in …
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS‐CoV‐2 Subunit Vaccine
Most vaccines require several immunizations to induce robust immunity, and indeed, most
SARS‐CoV‐2 vaccines require an initial two‐shot regimen followed by several boosters to …
SARS‐CoV‐2 vaccines require an initial two‐shot regimen followed by several boosters to …
COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response
JF Affonso de Oliveira, Z Zhao, Y ** Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
Z Ren, C Shen, J Peng - Viruses, 2023 - mdpi.com
The monoclonal antibody (mAb)-based treatment is a highly valued therapy against COVID-
19, especially for individuals who may not have strong immune responses to the vaccine …
19, especially for individuals who may not have strong immune responses to the vaccine …
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses
AE Powell, H Caruso, S Park, JL Chen, J O'Rear… - bioRxiv, 2024 - biorxiv.org
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified as a human
pathogenic virus in 2012 and is causing ongoing sporadic infections as well as outbreak …
pathogenic virus in 2012 and is causing ongoing sporadic infections as well as outbreak …
Research on the global trends of COVID-19 associated acute kidney injury: a bibliometric analysis
W Zhao, R Tan, J Gao, H Su, L Wang, J Liu - Renal Failure, 2024 - Taylor & Francis
Critically ill COVID-19 patients may exhibit various clinical symptoms of renal dysfunction
including severe Acute Kidney Injury (AKI). Currently, there is a lack of bibliometric analyses …
including severe Acute Kidney Injury (AKI). Currently, there is a lack of bibliometric analyses …